Natco Pharma Q1 net, revenue slump on lower cancer drug sales
Decline largely attributable to Lenalidomide revenue, generic drugmaker said as its shares tumbled more than 5%
· 8/14/2026, 12:41:45 PM· 2 min read
Decline largely attributable to Lenalidomide revenue, generic drugmaker said as its shares tumbled more than 5%
Read original story →
